
10 Evidence-Based Health Benefits of Whey Protein
Whey is a liquid that separates from milk during cheese production. The protein part of whey is called whey protein.
It's a complete, high quality protein that contains all of the essential amino acids. In addition, it's very digestible and absorbed from your gut quickly compared with other types of protein.
These qualities make it one of the best dietary sources of protein available.
Keep reading to learn more about 10 possible health benefits of whey protein.
1. Whey is an excellent source of high quality protein
As a dietary supplement, whey protein is widely popular among bodybuilders, athletes, and others who want additional protein in their diet.
There are three main types of whey protein powder, which are classified by their final protein concentration:
Concentrate (WPC): equal to or less than 89%
Isolate (WPI): equal to or greater than 90%
Hydrolysate (WPH): variable
WPC is the most common type and is usually the most affordable. WPI typically has the highest amount of protein and the fewest calories, as it's mostly protein. But it's usually more expensive.
2. May promote muscle growth
Protein is one of the most important nutrients for maintaining or preventing muscle loss, especially as you get older. It can support the growth and recovery of cells necessary for muscle energy, tissue growth, and restoration.
Whey protein, in particular, is known as a complete protein because it contains all nine essential amino acids your body needs, but can only be obtained through diet. It's also rich in a branched-chain amino acid called leucine, which is the most growth-promoting of the amino acids.
Some research suggests that whey protein supplementation may play an important role in preventing and managing age-related muscle loss, known as sarcopenia. It may help build muscle mass and improve strength.
However, it's important to note that resistance training should be a key part of anyone's weekly routine to help build muscle, regardless of age. Protein alone cannot support muscle growth.
As such, the most effective strategy for muscle building is a combination of strength training and consuming a balanced diet of high protein foods, carbohydrates, and some healthy fats.
3. May lower blood pressure
High blood pressure (hypertension) is one of the leading risk factors for heart disease.
A 2023 review of 18 studies found that whey protein supplementation may help reduce systolic blood pressure. This refers to the pressure between the arteries when your heart beats. It's the top number in a blood pressure reading.
The researchers also noted that whey protein may affect diastolic blood pressure when consuming more than 30 grams (g) of WPI per day, for 10 weeks, in people with a body mass index (BMI) of 25 to 30.
This effect may be due to a family of bioactive peptides in dairy called angiotensin-converting enzyme inhibitors (ACE inhibitors). In particular, lactokinins.
However, more research is needed to understand whey protein's possible effects on blood pressure.
A 2019 study in people with overweight and mild to moderate hypertension found that taking 30 g of whey protein daily for 12 weeks helped reduce systolic blood pressure, but not diastolic.
The authors concluded that the effects on blood pressure may have been due to weight loss, among other factors.
4. May help manage type 2 diabetes
Type 2 diabetes is a chronic disease characterized by high blood sugar and impaired insulin function. Insulin is a hormone that stimulates the uptake of blood sugar into cells, keeping it within healthy limits.
Research suggests that whey protein supplementation may help manage diabetes in several ways, including:
lowering blood sugar levels after eating
increasing insulin levels and sensitivity to its effects
managing blood glucose levels
increasing levels of fullness
lowering lipids, such as triglycerides
As a result, whey protein may be effectively used as a supplementary treatment for type 2 diabetes.
However, make sure to choose whey protein products that have minimal amounts of added sugars and carbs, as these can impact your blood glucose levels.
5. May help reduce inflammation
Inflammation is part of the body's response to damage. Short-term inflammation can be beneficial, but under certain circumstances, it may become chronic.
Chronic inflammation is a risk factor for many health conditions, including heart disease, diabetes, and arthritis, and it may reflect underlying health conditions or lifestyle habits that could harm health.
A 2022 review found that whey protein supplementation helped reduce C-reactive protein (CRP) and interleukin-6 (IL-6), two key markers of inflammation in the body.
6. May help manage inflammatory bowel disease
Inflammatory bowel disease (IBD) is a condition characterized by chronic inflammation in the lining of the digestive tract. It's a collective term for Crohn's disease and ulcerative colitis.
A 2024 review of human and animal studies suggests that whey protein supplementation may help promote IBD remission and prevent flare-ups by:
secreting an intestinal protein called mucin
reducing inflammation
improving the function of the intestinal barrier
supporting the gut microbiome and improving overall gut health
7. May enhance the body's antioxidant defenses
Antioxidants are substances that act against oxidation in the body. This means they reduce oxidative stress and lower the risk of various chronic diseases.
According to a 2018 review, some in vitro studies found that whey protein may boost natural antioxidant defenses, especially glutathione, which his produced by your body.
However, limited research has examined the effects of whey protein on antioxidants in humans.
The researchers also noted that for whey protein to have any significant antioxidant effects, it must be processed through the gut and enter the bloodstream.
As such, more research is needed to understand the effects of whey protein on antioxidants.
8. May have beneficial effects on blood fats
High cholesterol, especially LDL (bad) cholesterol, is a risk factor for heart disease.
Some research suggests that a combination of exercise and whey protein supplementation may help reduce LDL cholesterol and total cholesterol, especially in people younger than 50 years old.
In studies that lasted 12 weeks or longer, whey protein supplementation also helped reduce triglyceride levels.
9. May help reduce hunger
Satiety is a term used to describe the feeling of fullness we experience after eating a meal. It's the opposite of appetite and hunger, and it should suppress cravings for food and the desire to eat.
Some foods are more satiating than others, an effect which partly depends on their macronutrient (protein, carb, fat) composition.
Some research suggests that protein is the most filling of the three macronutrients. It can help increase several fullness hormones, including:
glucagon-like peptide-1 (GLP-1)
cholecystokinin (CCK)
peptide tyrosine-tyrosine (PYY)
However, not all proteins have the same effect on satiety. Whey protein appears to be more satiating than other types of protein, such as casein and soy, but more research is needed.
10. May help support weight management
Increased consumption of protein is a well-known weight loss strategy.
Eating more protein may help support fat loss by:
increasing feelings of fullness
reducing hunger and cravings throughout the day
increasing the thermic effect of food
maintaining muscle mass
Whey protein has been shown to be particularly effective, especially when combined with frequent exercise and maintaining a calorie deficit.
What are the possible side effects of whey protein?
In general, whey protein is well tolerated when consumed at the recommended dosage. This is usually 25 to 50 g per day (1 to 2 scoops), but some products will include other recommendations on the packaging.
Some people report that taking too much protein may cause mild gastrointestinal symptoms. These possible symptoms may include:
bloating
cramping
flatulence
diarrhea
abdominal discomfort
If you have lactose intolerance, whey protein hydrolysate or isolate may be more suitable than concentrate. It's also important to speak with a doctor before taking whey protein supplements if you have liver or kidney problems.
»More on this: Side effects of protein supplements
The bottom line
Whey protein powder is one of the most common supplements for athletes, bodybuilders, and people trying to increase their daily protein intake.
It may have several health benefits, such as promoting muscle growth and helping to manage conditions like diabetes, hypertension, and high cholesterol.
If you have a kidney or liver condition, speak with a healthcare professional before taking whey protein supplements. They could recommend a proper dose for you or an alternative way to increase your protein intake.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Electrophysiology Market worth US$21.72 billion by 2030 with 11.6% CAGR
DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The global Electrophysiology Market, valued at US$11.41 billion in 2024, stood at US$12.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$21.72 billion by the end of the period. The rise of the electrophysiology market can be attributed to several drivers: the increasing prevalence of cardiovascular diseases, including arrhythmias and atrial fibrillation; patients and healthcare providers are increasingly favoring minimally invasive procedures over traditional surgical interventions; electrophysiological techniques, such as catheter ablation, offer less invasive options for treating certain cardiac arrhythmias; and government support and initiatives aimed at improving healthcare infrastructure and funding research and development in electrophysiology also contribute to market growth. Download PDF Brochure: Browse in-depth TOC on "Electrophysiology Market" 322 - Tables62 - Figures330 - Pages By product, in 2024, electrophysiology ablation catheters are expected to be the leading segment in the medical device market. This anticipated growth is largely driven by the rising global prevalence of atrial fibrillation (AF) and various cardiac arrhythmias, which has increased the demand for minimally invasive ablation techniques. Recent technological advancements in catheter design, such as the introduction of contact force-sensing mechanisms, irrigated-tip designs, and high-power short-duration (HPSD) ablation systems, have greatly enhanced procedural safety, precision, and clinical outcomes. These innovations are contributing to wider acceptance and increased utilization of these catheters within the medical community. By indication, the electrophysiology market, divided by medical indications, includes segments such as atrial fibrillation, atrial flutter, and atrioventricular nodal reentry tachycardia. Atrial flutter, characterized by rapid heartbeats from the atria, is increasingly common, especially among the elderly, due to age-related cardiac changes. This rising prevalence has created a demand for advanced diagnosis and treatment options tailored to atrial flutter. Innovations in catheter ablation, advanced imaging techniques, and new pharmacological therapies reflect the urgency for effective arrhythmia management in an aging population. By geography, in 2024, North America, primarily the US and Canada, is set for significant growth in the medical technology market. The region is a global leader in medical innovations, especially in electrophysiology, often adopting breakthroughs ahead of others. With some of the highest healthcare spending globally, the US influences the uptake of advanced medical technologies, enhancing patient outcomes and operational efficiency. Strong A investment in research and development fosters innovation and creates a robust marketplace for new products and services, solidifying North America's role as a key driver of growth in the medical technology sector. Request Sample Pages : As of 2024, prominent players in the electrophysiology market are Johnson & Johnson Services, Inc. (US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Boston Scientific Corporation (US), Japan Lifeline Co., Ltd (Japan), Stereotaxis, Inc. (US), MicroPort Scientific Corporation (China), and BIOTRONIK (Germany). Abbott (US): Abbott Laboratories is a comprehensive healthcare company that operates across diverse sectors, including pharmaceuticals, medical devices, diagnostics, and nutrition. The company has established a significant presence in electrophysiology, particularly in the development of advanced medical devices for cardiac electrophysiology procedures. Abbott's portfolio in this specialized market includes sophisticated mapping systems, electrophysiology catheters, and related technologies designed for the precise diagnosis and management of cardiac arrhythmias. Furthermore, Abbott is likely engaged in ongoing research and development initiatives aimed at innovating and enhancing electrophysiological technologies to improve patient outcomes and procedural efficiencies. Koninklijke Philips N.V. (Netherlands) Koninklijke Philips N.V. Philips, a Netherlands-based multinational company, is a significant player in the healthcare sector, particularly within medical technology. The company develops an extensive range of products that enhance capabilities in cardiology, patient monitoring, diagnostic imaging, and electrophysiology. In the electrophysiology domain, Philips offers advanced solutions aimed at the identification and management of cardiac arrhythmias. This product suite includes high-precision imaging technologies, advanced mapping systems, and specialized electrophysiology catheters, all essential tools utilized by cardiology professionals. Key offerings include the EP WorkMate system, which serves as a comprehensive electrophysiology recording and reporting platform, facilitating efficient data capture and analysis during procedures. Additionally, Philips has introduced state-of-the-art X-ray imaging systems designed for enhanced visualization during electrophysiological interventions. The EP Navigator and EP-XT Mapping system are also part of their innovative portfolio, providing clinicians with advanced three-dimensional mapping capabilities that improve procedural accuracy and patient outcomes. For more information, Inquire Now! Related Reports: Defibrillator Market Cardiac Monitoring & Cardiac Rhythm Management Devices Market Ablation Technology Market Catheters Market Digital X-ray Market Get access to the latest updates on Electrophysiology Companies and Electrophysiology Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets
Yahoo
4 minutes ago
- Yahoo
UnitedHealth stock pops on Buffett's Berkshire share purchase
UnitedHealth Group's (UNH) stock jumped early Friday after Warren Buffett's Berkshire Hathaway (BRK-A, BRK-B) revealed Thursday it purchased 5 million shares last quarter. The insurance giant has suffered multiple setbacks in the past couple of years — with earnings misses piling on top of all that, the stock has been under constant pressure, and is down more than 45% year-to-date. But on the news of Berkshire's share purchase, the stock popped nearly 10% in early trading Friday. The last time Berkshire held a stake in the company was when Stephen Hemsley was CEO, between 2006 and 2017. Hemlsey has returned to the role after former CEO Andrew Witty stepped down in May — after a year of compounding headwinds. Last year, the company suffered one of the biggest cyberattacks in history on one of it's subsidiaries, Change Healthcare, which manages payments — creating havoc for health providers for months. The US Health and Human Services Department (HHS) had to step in and assist to help get payments flowing again. The company subsequently announced a larger-than-expected impact from the attack in mid-2024, dragging down major indices. At the end of the year, during the annual shareholder's meeting in New York City, insurance CEO Brian Thompson was shot to death. The struggles for the company didn't end there, as public backlash against the industry swelled in the aftermath, and the entire insurance industry was forced to address the issue of denied claims. In April this year, the company's stock crashed after an earnings miss shocked the Street. In May, Hemsley took over, and in the latest earnings call addressed the missteps the company has made, as well as the higher cost environment that it did not adjust in time to. "Beyond the environmental factors that are affecting the entire sector and more specifically to us, we have made pricing and operational mistakes as well as others," he said on the call. UnitedHealth's stock pop also helped boost the Dow (DJI), which was up about a half percent in early trading. Previously, UnitedHealth's losses dragged the Dow. In May, UnitedHealth was attributed with 88% of the Dow's decline year-to-date. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Click here for in-depth analysis of the latest health industry news and events impacting stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Buffett Just Bought the Dip--Is This Health Giant the Comeback Play of the Year?
UnitedHealth Group (NYSE:UNH) just caught a lifelinestraight from two of Wall Street's most respected investors. Shares jumped 8.75% at 9.31am today, marking the stock's biggest intraday gain since 2020. The catalyst? Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway disclosed a fresh 5 million-share stake, while David Tepper (Trades, Portfolio)'s Appaloosa Management added another 2.3 million shares. That's a bold vote of confidence for a company that's been hammered this year, down 46% amid regulatory heat and earnings disappointments. Warning! GuruFocus has detected 5 Warning Sign with UNH. The health insurance heavyweight is navigating one of the roughest stretches in its history. A top executive was murdered late last year. In April, the company slashed its full-year outlook, then replaced its CEO with former chief Stephen Hemsley. Most recently, UnitedHealth issued a fresh profit forecast that came in below every single analyst estimatea stunning reversal for a business that had beaten expectations for over 60 straight quarters. So what broke the streak? UnitedHealth underestimated how quickly Americans would return to using medical servicesand set premiums too low as a result. Meanwhile, changes in government-subsidized coverage and payment models are eating into margins. If this trend holds, 2025 could mark the first annual adjusted EPS decline in nearly 20 years. Still, Buffett and Tepper stepping in suggests they see something others don't: a dominant business under temporary pressure, with long-term upside hiding in the wreckage. This article first appeared on GuruFocus.